NeuroSense Therapeutics (NRSN) Receivables (2020 - 2023)
NeuroSense Therapeutics' (NRSN) quarterly Receivables came in at $472000.0 in Q4 2023, down 7.45% year-over-year from $510000.0 in Q4 2022, and down 7.45% quarter-over-quarter from $510000.0 in Q4 2022.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Receivables (2020 - 2023) Analysis & Trends
NeuroSense Therapeutics has disclosed Receivables across 4 years of filings, most recently posting $472000.0 for Q4 2023.
- In Q4 2023, Receivables fell 7.45% year-over-year to $472000.0; the TTM figure through Dec 2023 stood at $472000.0 (down 7.45% YoY), while the FY2023 annual figure was $472000.0, down 7.45% from the prior year.
- Receivables came in at $472000.0 for Q4 2023 at NeuroSense Therapeutics, down from $510000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $510000.0 in Q4 2022 to a low of $60000.0 in Q4 2020.
- Average Receivables over 4 years is $357000.0, with a median of $429000.0 recorded in 2021.
- Year-over-year, Receivables surged 543.33% in 2021 and decreased 7.45% in 2023.
- Over 4 years, Receivables stood at $60000.0 in 2020, then surged by 543.33% to $386000.0 in 2021, then jumped by 32.12% to $510000.0 in 2022, then slipped by 7.45% to $472000.0 in 2023.
- Per Business Quant data, the three most recent Receivables figures were $472000.0 in Q4 2023, $510000.0 in Q4 2022, and $386000.0 in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 160.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 1.93 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | - |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 472,000.00 |
| Dec 31, 2022 | 510,000.00 |
| Dec 31, 2021 | 386,000.00 |
| Dec 31, 2020 | 60,000.00 |
API Access
NeuroSense Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();